MedTrace Logo

USCOM in Newly Diagnosed FGR Cases

NCT06343051 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-02-10

No results posted yet for this study

Summary

The purpose of this research study is to study the use of an ultrasound measurement system (USCOM) for patients with newly diagnosed fetal growth restriction (FGR). This system uses a technology to measure how much blood is being pumped in and out of the heart, which is important for understanding the heart's function in relation to pregnancy.

Conditions

  • Fetal Growth Restriction
  • USCOM

Interventions

DEVICE

USCOM

Device that measures how much blood is being pumped in and out of the heart.

Sponsors & Collaborators

Principal Investigators

  • Nicola F Tavella, MPH · Icahn School of Medicine at Mount Sinai

  • Rachel J Meislin, MD · Icahn School of Medicine at Mount Sinai

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-02
Primary Completion
2026-06-30
Completion
2026-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06343051 on ClinicalTrials.gov